RecruitingNot ApplicableNCT07663994

Analytical Validation of Circulating DNA Analysis Methods: Creation of a Control Cohort

Sponsor

Institut Claudius Regaud

Enrollment

68 participants

Start Date

Jul 16, 2026

Study Type

INTERVENTIONAL

Conditions

Healthy Volunteers (Cancer)

Summary

Pilot, prospective, mono-center study conducted in a population of healthy participants (free of cancer) for the analytical validation of circulating DNA analysis methods. The participants are employees of the institution. Their recruitement is carried out via internal posting (intranet and bulletin boards). The study participation will be strictly voluntary and without consequences on the professional situation of the participants.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 1 single blood draw after in the inclusion of the participant in the study (Up to 30 mL). for people with healthy volunteers (cancer). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TEST1 single blood draw after in the inclusion of the participant in the study (Up to 30 mL).

The samples will be processed by the laboratory as follows: - extraction of circulating DNA; - NGS Sequencing on 2 gene-panels; - capillary electrophoresis; - digital PCR

Locations(1)

Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07663994